Salute e Benessere

Novo Nordisk to present Wegovy® and Ozempic® data showing life-saving…

Data to highlight the impact of Wegovy® (semaglutide 2.4 mg) on atrial fibrillation – a common heart rhythm condition – in people living with obesity (SELECT study)Additional Rybelsus ®and Ozempic ®data demonstrate new cardiometabolic benefits (improvements in heart and metabolic health) in people living with type 2 diabetes (SOUL and STRIDE studies)New insights into the role of inflammation in cardiovascular disease on mortality and major cardiovascular events in people living...
Nasdaq GlobeNewswire
20/08/2025

True Classic Renews Partnership with Global-e Following International Success…

Since partnering with Global-e, True Classic has rapidly expanded its global online footprint, growing from a digital-native brand serving only the U.S. and Canada to reaching over 200 international markets. Today, international sales account for over 25% of True Classic's total e-commerce revenue, with key markets including Canada, the UAE, the UK, Australia, Switzerland, Norway, and Sweden. Since partnering with Global-e, True Classic has rapidly expanded its global online footprint…
PR Newswire
20/08/2025

Ping An Good Doctor (1833.HK) Reports Solid Interim Results with Steady Revenue…

In the first half of 2025, the Company's core businesses performed steadily, with revenue from the integrated finance business ("F-end") and corporate clients ("B-end") corporate health management business increased by 30.2% year-on-year. As two major core hubs, family doctor services and senior care concierge services, continuously improved service standards and efficiency, leading to a significant increase in member coverage. Specifically, the Company had over 35.0 million…
PR Newswire
20/08/2025

Dietary Supplements Testing Market worth $3,652.2 million by 2030- Exclusive…

Browse in-depth TOC on "Dietary Supplements Testing Market"200– Tables40– Figures250– Pages Browse in-depth TOC on "Dietary Supplements Testing Market" 200– Tables 40– Figures 250– Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=227592621 Traditional testing services segment to hold significant market share during forecast period In the dietary supplements testing market, traditional testing services are expected to hold a significant...
PR Newswire
20/08/2025

Alvotech appoints Patrik Ling as VP of Investor Relations Scandinavia

REYKJAVIK, ICELAND (August 20, 2025)— Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that Patrik Ling has joined the company as VP Investor Relations Scandinavia, based in Stockholm.Patrik Ling has more than 25 years of experience in the life-science industry. Most recently he served as Senior Equity Analyst at the investment bank DNB Carnegie, covering life science...
Nasdaq GlobeNewswire
20/08/2025

/C O R R E C T I O N -- Dubai Humanitarian/

- Launches on World Humanitarian Day, 19 August 2025 - Launches on World Humanitarian Day,19 August 2025 - First six months of 2025 saw$48.8mhumanitarian aid distributed from Dubai Humanitarian, reflected in its Humanitarian Logistics Databank DUBAI, UAE, Aug. 19, 2025 /PRNewswire/ -- Dubai Humanitarian, the world's largest humanitarian logistics hub, has unveiled a new documentary, Coming Together: The Dubai Humanitarian Story- a gripping behind-the-scenes look at...
PR Newswire
20/08/2025

Sai Life Sciences secures SBTi validation for near-term climate targets

Contract Research, Development, and Manufacturing Organization (CRDMO), announced that its near-term targets to cut greenhouse gas (GHG) emissions have been validated by the Science Based Targets initiative (SBTi)—a corporate climate action organization that enables companies and financial institutions worldwide to play their part in combating the climate crisis. Making the announcement,Krishna Kanumuri, CEO & Managing Director, Sai Life Sciences, said:"As a CRDMO, our impact...
Nasdaq GlobeNewswire
20/08/2025

The rise of "Speed Laundering" - Electrolux report reveals convenience reshaping…

Extending the life of clothing is a highly effective way to reduce the fashion industry's substantial environmental impact. [1] The industry generates more greenhouse gasesthan all international flights and shipping combined. [2] Additionally, Europeans discard about 16kg of textile waste per person annually, with 88% ending up in landfills or being incinerated [3], despite most items still being usable. [4] According to the Electrolux Care Index, published in 2024, consumers who choose shorter…
PR Newswire
20/08/2025

337,000 Orion Corporation A shares converted into B shares

ORION CORPORATIONSTOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE20 AUGUST 2025 at 9.00 EEST 337,000 Orion Corporation A shares converted into B shares In accordance with Section 3 of the Articles of Association of Orion Corporation, 337,000 A shares have been converted into 337,000 B shares. The conversion has been entered into the Trade Register on 20 August 2025.The total number of shares in Orion Corporation is 141,134,278...
Nasdaq GlobeNewswire
20/08/2025

Zelluna ASA Reports Second Quarter 2025 Financial Results and Provides General…

Oslo, Norway, 20 August 2025 – Zelluna (OSE: ZLNA), a company pioneering allogeneic “off-the-shelf” T-cell receptor-based natural killer (TCR-NK) therapies for the treatment of cancer, announces its second quarter 2025 results today.Webcast scheduled for 20 August 2025, at 09:00 (CET). Link to webcast here . Second Quarter 2025 Business UpdateHighlightsOn track toward IND/CTA submission in 2H 2025 and first-in-human trial initiation in 1H 2026. Broadened...
Nasdaq GlobeNewswire
20/08/2025

Heidelberg University Hospital expands its particle therapy program with IBA’s…

Louvain-La-Neuve, Belgium, August 20, 2025 –IBA(Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer and Heidelberg University Hospital (Universitätsklinikum Heidelberg AöR, UKHD) announce today that they have signed a contract to install a Proteus ® ONE 1compact proton therapy solution to be located on the University campus in Heidelberg, Germany. The first...
Nasdaq GlobeNewswire
20/08/2025

Vital Materials Released Quantum Flux Photon Counting CT (PCCT) Full Vertical…

Currently, the PCCT detectors primarily utilize three materials: Cadmium Zinc Telluride (CdZnTe or CZT), Cadmium Telluride (CdTe), and Deep Silicon. CZT is emerging as a breakthrough for next-generation medical imaging technology due to its outstanding detection capabilities. The core value of VITA Genesis lies not only in adopting a detector solution based on the CZT, but more importantly in pioneering the mastery of PCCT's full vertical integration technology. This includes ultra-high purity…
PR Newswire
20/08/2025

Global Personal Care Contract Manufacturing Market to Cross USD 40 Billion by…

Key Takeaways from the Personal Care Contract Manufacturing Market Report Key Takeaways from the Personal Care Contract Manufacturing Market Report To read more about the latest highlights related to the personal care contract manufacturing market, get a snapshot of the key highlights entailed in theGlobal Personal Care Contract Manufacturing Market Report Personal Care Contract Manufacturing Overview Personal care contract manufacturing refers to outsourcing the production...
PR Newswire
19/08/2025

FGFR Inhibitors Market Set to Surge by 2034 as Targeted Cancer Therapies…

Key Takeaways from the FGFR Inhibitors Market Report Key Takeaways from the FGFR Inhibitors Market Report Discover which indication is expected to grab the major FGFR inhibitors market share @FGFR Inhibitors Market Report FGFR Inhibitors Market Dynamics The FGFR inhibitors market is evolving rapidly, driven byincreased understanding of the FGFR signaling pathway's rolein oncogenesis and other diseases. FGFR alterations, such as fusions, mutations, and amplifications, are...
PR Newswire
19/08/2025

IPSEN - Buy-back programme - Art 5 of MAR - Week 33 - 2025

Aggregated presentation by day and by marketStatement of transactions in own shares from August 11th to August 15th 2025 Name of the issuerIdentity code of the issuer(Legal Entity Identifier) Day of the transactionIdentity code of the financial instrument Total daily volume (in number of shares)Daily weighted average purchase price of the sharesMarket (MIC Code)IPSEN549300M6SGDPB4Z94P1111/08/2025FR0010259150 300...
Nasdaq GlobeNewswire
19/08/2025

TRYVIO™ (aprocitentan) now included in ACC/AHA Clinical Practice Guidelines for…

The updated recommendations now include TRYVIO™ (aprocitentan) – the first and only hypertension treatment targeting the endothelin pathway.Endothelin is upregulated in hypertension and is a fundamental mediator in patients whose hypertension is difficult-to-control.Hypertension remains a major global health issue, and the number one modifiable risk factor of early morbidity/mortality.Allschwil, Switzerland & Radnor, Pennsylvania – August 19, 2025Idorsia Ltd (SIX: IDIA)...
Nasdaq GlobeNewswire
19/08/2025

Real World Evidence Solutions Market worth $10.83 billion by 2030 with 14.8%…

Browse in-depth TOC on "Real World Evidence Solutions Market"190 - Tables60 - Figures265 - Pages Browse in-depth TOC on "Real World Evidence Solutions Market" 190 - Tables 60 - Figures 265 - Pages By component,the real-world evidence solutions market is segmented into services, data sets, and integrated data sets. The services segment accounted for the largest share of the market in 2024. The services segment comprises advanced analytics services and consulting services...
PR Newswire
19/08/2025

Healthcare Analytics Market to Grow at a CAGR of 22.3% from 2025 to 2032 |…

Get a Free Sample Report: https://www.skyquestt.com/sample-request/healthcare-analytics-market Get a Free Sample Report:https://www.skyquestt.com/sample-request/healthcare-analytics-market Healthcare Analytics Market Key Growth Drivers The healthcare analytic market has experienced significant growth owing to these tools help identify inefficiencies, forecast resource utilization, and prevent unnecessary procedures. By enabling data-driven financial decisions, healthcare analytics...
PR Newswire
19/08/2025

Fill Finish Manufacturing Market worth $28.14 billion by 2030 with 8.9% CAGR |…

Browse in-depth TOC on "Fill Finish Manufacturing Market" Browse in-depth TOC on "Fill Finish Manufacturing Market" 601 - Tables51 - Figures466 - Pages By product type,the global fill finish manufacturing market is segmented by product type into two main categories: consumables and instruments. In 2024, the consumables segment accounted for the leading contributor to the global fill finish manufacturing market. This is largely driven by the escalating demand for...
PR Newswire
19/08/2025

Coloplast A/S - Interim Financial Report, 9M 2024/25

Coloplast A/S - Interim Financial Report, 9M 2024/252024/25 Interim financial results, 9M 2024/25 1 October 2024 - 30 June 2025 Coloplast delivered organic growth of 7% and an EBIT margin 1 of 28% in Q3. Reported revenue in DKK grew 1% with negative impact from currencies and the Skin Care divestment.Organic growth rates by business area: Ostomy Care 6%, Continence Care 8%, Voice and Respiratory Care 9%, Advanced Wound Care 4% and Interventional Urology 4%.Growth in...
Nasdaq GlobeNewswire
19/08/2025

12.6% CAGR for Cancer Drugs Market to Reach US$516.15 billion by 2031, Due to…

The burden is projected to increase by ~77% by 2050, further straining health systems and communities. According to the American Cancer Society, genes inherited from parents are responsible for 5–10% of all cancers. The highest rates are observed in Australia, North America, New Zealand, and Northern Europe, while mortality disproportionately affects low-HDI nations due to limited screening and access to care. The burden is projected to increase by ~77% by 2050, further straining health…
PR Newswire
19/08/2025

Coloplast A/S – Updated presenters list for Capital Markets Day on 2 September…

Following the changes to the Executive Leadership Team, announced on 19.08.2025*, we are pleased to share with you the updated presenters list for our Capital Markets Day on 2 September 2025. For those of you who have signed up, we look forward to seeing you at the event. The event will take place on Tuesday, 2 September 2025 at Clarion Hotel (Copenhagen airport) Ellehammersvej 20, 2770 Kastrup from 10.30 - 17.00 CEST(Central European Summer Time)The event will be held in...
Nasdaq GlobeNewswire
19/08/2025

LabConnect Launches LabConnector™ to Streamline Lab Data Integration

LabConnector is purpose-built for IT teams and data analysts at sponsor organizations who need streamlined, secure, and accurate laboratory data for ongoing clinical trials. With seamless integration to any LabConnect partner, it delivers unmatched flexibility for clinical operations and data management. LabConnector is purpose-built for IT teams and data analysts at sponsor organizations who need streamlined, secure, and accurate laboratory data for ongoing clinical trials. With seamless...
PR Newswire
19/08/2025

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives…

Bagsværd, Denmark, 19 August 2025 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse. The company’s board members, executives and their associated persons have reported the transactions to Novo Nordisk. 1 Details of the person discharging managerial responsibilities/person closely associated...
Nasdaq GlobeNewswire
19/08/2025
Altri  Comunicati